CLBCore Laboratories Inc.
Is it safe?
Mostly sound, with a caveat: comfortable debt (AA), but big price swings.
Rock-solid balance sheet, low leverage. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -94% · now 48% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can CLB take a bad year?
Core Laboratories Inc. carries $91M of net debt at 1.46× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 1.46×
Net debt / EBITDA · 1.37× a year ago · the load is going up
- Interest cover
- 4.35×
Interest cover · operating profit covers the interest bill, with room to spare
- Annualised volatility
- 56%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtQ2 2026
- $114M
- Cash and short-term investments
- $23M
- Net debt
- $91M
- EBITDA, trailing twelve months
- $63M
- Operating profit, trailing twelve months
- $48M
- Debt / equity
- 0.42×
- Total debt / EBITDA
- 1.82×
- Annualised volatilitytwo years of daily moves
- 56%
- Worst drawdown on file
- −94%
- Below its 52-week high
- 48%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.